519 related articles for article (PubMed ID: 32520599)
1. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
Frank S; Capriotti J; Brown SM; Tessema B
Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
[TBL] [Abstract][Full Text] [Related]
3. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
Khan MM; Parab SR; Paranjape M
Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
[TBL] [Abstract][Full Text] [Related]
4. Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic.
Chorney SR; Rizzi MD; Dedhia K
Am J Otolaryngol; 2020; 41(6):102737. PubMed ID: 32979667
[TBL] [Abstract][Full Text] [Related]
5. Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery.
Parhar HS; Tasche K; Brody RM; Weinstein GS; O'Malley BW; Shanti RM; Newman JG
Head Neck; 2020 Jun; 42(6):1268-1272. PubMed ID: 32333619
[TBL] [Abstract][Full Text] [Related]
6. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
[TBL] [Abstract][Full Text] [Related]
7. Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework.
Naqvi SHS; Citardi MJ; Cattano D; Ostrosky-Zeichner L; Knackstedt MI; Karni RJ
J Otolaryngol Head Neck Surg; 2020 Oct; 49(1):77. PubMed ID: 33109269
[TBL] [Abstract][Full Text] [Related]
8. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses.
Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
J Prosthodont; 2020 Aug; 29(7):599-603. PubMed ID: 32608097
[TBL] [Abstract][Full Text] [Related]
9. Use of oral antiseptics for SARS-CoV-2 infection.
Palop Larrea V; Hernández Rodríguez MÁ
Med Clin (Barc); 2020 Nov; 155(9):416-417. PubMed ID: 32778429
[No Abstract] [Full Text] [Related]
10. 0.5% povidone iodine irrigation in otorhinolaryngology surgical practice during COVID 19 pandemic.
Khan MM; Parab SR
Am J Otolaryngol; 2020; 41(6):102687. PubMed ID: 32861125
[No Abstract] [Full Text] [Related]
11. In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2.
Frank S; Brown SM; Capriotti JA; Westover JB; Pelletier JS; Tessema B
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1054-1058. PubMed ID: 32940656
[TBL] [Abstract][Full Text] [Related]
12. A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19.
Benson KM; Mancini AA; Brodeur MR
Sr Care Pharm; 2021 May; 36(5):238-241. PubMed ID: 33879284
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: Ophthalmic prophylactic and therapeutic measures.
Waikar S; Oli A
Indian J Ophthalmol; 2020 Jun; 68(6):1223-1224. PubMed ID: 32461492
[No Abstract] [Full Text] [Related]
14. Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection.
Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013626. PubMed ID: 32936949
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them.
Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013627. PubMed ID: 32936948
[TBL] [Abstract][Full Text] [Related]
16. Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV.
Sarma P; Kaur H; Medhi B; Bhattacharyya A
Graefes Arch Clin Exp Ophthalmol; 2020 Nov; 258(11):2563-2565. PubMed ID: 32436084
[No Abstract] [Full Text] [Related]
17. A Surgical Protocol to Mitigate the SARS-CoV-2 Transmission Using Multifocal Povidone-Iodine Applications in Lacrimal Surgeries During Coronavirus Disease 2019 (COVID-19) Pandemic.
Ali MJ
Ophthalmic Plast Reconstr Surg; 2020; 36(4):416-417. PubMed ID: 32496394
[No Abstract] [Full Text] [Related]
18. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
[TBL] [Abstract][Full Text] [Related]
19. Virucidal effect of povidone-iodine against SARS-CoV-2
Wang Y; Wu Y; Wang Q; Zhu J; Shi W; Han Z; Zhang Y; Chen K
J Int Med Res; 2021 Dec; 49(12):3000605211063695. PubMed ID: 34914884
[TBL] [Abstract][Full Text] [Related]
20. Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.
Lim NA; Teng O; Ng CYH; Bao LXY; Tambyah PA; Quek AML; Seet RCS
Ann Med; 2022 Dec; 54(1):1488-1499. PubMed ID: 35594333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
